The Silicon Valley Podcast · 2026-06-21 · 39 min
Guest: Carrie Freeman Title: CEO, Eden Radioisotopes Company: Eden Radioisotopes, LLC LinkedIn: Episode Overview In this episode, we sit down with Carrie Freeman, CEO of Eden Radioisotopes, to explore the intersection of deep science, commercialization, and leadership. After spending 15 years at Intel and serving as a multi-time CEO, Carrie has built a career around transforming breakthrough technologies into scalable businesses. We discuss what it takes to commercialize innovations emerging from national laboratories, the resurgence of the nuclear industry, and why private capital is increasingly driving the next generation of nuclear technologies. Carrie also shares her perspective on leadership transitions, fundraising for long-horizon ventures, and how organizations can remain focused on human impact while operating at the cutting edge of science.
Ep 289 Investing Beyond the Pitch & Building Great Companies with Alex Chompff61 / 100Ep 287 Reinventing Angel Investing, and the Future of Fintech-with Joshua SummersEp 285 The CEO Playbook - From Used Cars to AI Giants With Bryan MurphyEp 284 California at the Crossroads: Capital, Policy, and the Path Forward with Steve HiltonEp 283 Disrupting the System: Entrepreneurship, Governance, and the future of California with Elaine Culotti